Join us at IDWeek 2017

October 4–8, 2017    |    San Diego    |    Booth 541
Fast Phenotypic Antibiotic Susceptibilities for Patients with Bacteremia: Clinical Implementation of New Diagnostic Technology in a Large Academic Medical Center
Where:

IDWeek – Learning Lounge
San Diego Convention Center
Learning Lounge #2 (booth 1035)

When:

Saturday, October 7, 2017
1:15pm – 2:00pm

1:15-1:33 p.m.
Clinical Microbiology Laboratory Challenges & Opportunities:
Integrating Fast MIC Results into Laboratory Workflow & Antimicrobial Stewardship

Presented by Margie Morgan PhD, MT(ASCP), D(ABMM)
Professor, Pathology and Laboratory Medicine
Scientific Director, Microbiology
Cedars-Sinai Medical Center
Los Angeles, CA

1:33-1:51 p.m.
Management of Patients with Bacteremia Challenges & Opportunities:
Utility of Fast Phenotypic Antibiotic Susceptibilities in Patients with Serious Infections

Presented by Jonathan Grein, MD
Assistant Professor
UCLA School of Medicine
Director, Hospital Epidemiology
Co-Chair Antimicrobial Stewardship
Cedars-Sinai Medical Center
Los Angeles, CA

1:51-2:00 p.m.
Moderated Q&A and Audience Questions


Direct from Positive Blood Culture Phenotypic Antibiotic Susceptibilities: Implications for Stewardship & Future Applications
Where:

IDWeek – Presentation Theater
Marriott Marquis San Diego
Marina Ballroom E

When:

Saturday, October 7, 2017
6:00pm – 7:00pm

6:00-6:15 p.m.
Fast MIC Determination Utilizing Morphokinetic Cellular Analysis
Technical Overview and Data Review

Presented by Romney Humphries PhD, D(ABMM), M(ASCP)
Chief Scientific Officer
Accelerate Diagnostics
Tucson, AZ

6:15-6:30 p.m.
Management of Immunocompromised Patients with Gram Negative Bacteremia Utility of Fast MICs in Antimicrobial Stewardship Practice

Presented by Micah M. Bhatti, MD PhD
Assistant Professor, Division of Laboratory Medicine and Pathology
Technical Director, Clinical Microbiology Laboratory
The University of Texas, MD Anderson Cancer Center

6:30 – 6:45 p.m.
The Future of Single Cell Phenotypic Analysis
Scientific and Clinical Implications of Bacterial Heterogeneity

Presented by Michael J. Rybak, Pharm.D., M.P.H.
Professor, Department of Pharmacy Practice,
Wayne State University, Detroit, MI
Director, Anti-Infective Research Laboratory,
Eugene Applebaum College of Pharmacy & Health Sciences, Detroit, MI

6:45-7:00 p.m.
Moderated Q&A and Audience Questions


Poster Presentations

Date:
Saturday, October 7

Time:
12:30 p.m.

2026 - Performance Verification of the Accelerate Pheno™ system for Rapid Identification and Antimicrobial Susceptibility Testing from Positive Blood Culture in a Pediatric Population

Judy Daly
Primary Children's Hospital, Salt Lake City, UT

2029 - Evaluation of the Accelerate Pheno™ system for the identification and antimicrobial susceptibility testing of Gram-negative bacteria, compared with conventional laboratory testing.

K. Roulston, R. Gorton, E. Kazntzaki, M. Rebec, S. Hopkins, G. Satta, D. Mack
Royal Free London NHS Foundation Trust, London, United Kingdom

2031 - Prospective Evaluation of AcceleratePheno™ system (AXDX) Version 1.1 for Reducing Turn-Around-Time (TAT) in Identification/ Antimicrobial Susceptibility Testing (ID/AST) of Gram-Negative Bacilli (GNB)from Positive Blood Cultures (+BC) using AXDXPhenoTest™ BC kits

Barbara M. Willey, Bryan Gascon, Samantha Lee, Vita Koren, Salman Surangiwala, Aimee Paterson, Pauline Lo, Tony Mazzulli, and Susan M.Poutanen
Mount Sinai Hospital/University Health Network, Toronto, ON,Canada

2032 - Clinical Impact of Rapid Identification(ID) and Phenotypic Antimicrobial Susceptibility Testing (AST) by Accelerate Pheno™ system(AXDX) for Gram-negative (GNB) Bloodstream Infections

Nancy Matic, Barbara Willey, BryanGascon, Samantha Lee, Vita Koren, Salman Surangiwala, Pauline Lo, Tony Mazzulli, and Susan M. Poutanen
Mount Sinai Hospital/University Health Network, Toronto, ON,Canada

2038 - Retrospective Evaluation of AcceleratePheno™ system (AXDX, Version 1.1) for Identification/Antimicrobial Susceptibility Testing (ID/AST) of Gram-Negative Bacilli (GNB)including Carbapenemase-Producing Organisms(CPO) from Seeded Blood Culture Bottles (SBCB) Tested using AXDX PhenoTest™ BC kits

Barbara M. Willey, Bryan Gascon, Samantha Lee, Vita Koren, Salman Surangiwala, Aimee Paterson, Pauline Lo, David A. Boyd, Michael Mulvey, Tony Mazzulli, and Susan M. Poutanen
Mount Sinai Hospital/University Health Network, Toronto, ON,Canada

2040 - Analytical Performance Characteristics of the Accelerate Pheno™ system for Pathogen Identification and Susceptibility Testing for Gram-negative Bacteremia and Candidemia

Jason P. Burnham, Meghan A. Wallace,Brian M. Fuller, Carey-Ann D. Burnham, Marin H. Kollef
Barnes-Jewish Hospital/Washington University School of Medicine, St.Louis, MO

2089 - Accelerating Time to Pathogen-adapted Antibiotic Treatment through Culture independent Antimicrobial Susceptibility Testing in Patients suffering from Sepsis

Matthias Karrasch
Jena University Hospital, Jena, Germany

2119 - Clinical Impact of Expedited Pathogen Identification and Susceptibility Testing for Gram-negative Bacteremia and Candidemia Using the Accelerate Pheno™ system

Jason P. Burnham, Meghan A. Wallace, Brian M. Fuller, Carey-Ann D. Burnham, Marin H. Kollef
Barnes-Jewish Hospital/ Washington University School of Medicine. St. Louis, MO

2134 - Impact of Accelerate Pheno™ system on Time to Antimicrobial Stewardship Intervention in Patients with Gram-Negative Blood Stream Infections

Gerald Elliott, Michael Postelnick
Northwestern Memorial Hospital, Chicago, IL

Recent Publications

Jun 06, 2017

Use of Accelerate Pheno™ System for the Identification and Susceptibility (ID/AST) of Pathogens in Positive Blood Cultures and Impact on Time to Results and Workflow
ASM Microbe 2017

Jun 06, 2017

Evaluation of an Automated Platform for Rapid Identification and Antibiotic Sensitivity Testing of Bacteria Directly from Positive Blood Culture Bottles
ASM Microbe 2017

Jun 06, 2017

Evaluation of the Accelerate Pheno System for the Rapid Identification and Susceptibility of Gram-Negative Rods from Positive Blood Cultures
ASM Microbe 2017

Jun 06, 2017

Accelerate PhenoTest™ BC Kit vs. Conventional Methods for Identification and Antimicrobial Susceptibility Testing of Gram‐positive Bloodstream Isolates: Implications for Antimicrobial Stewardship
ASM Microbe 2017

See all publications

Learn about our

Technology

What it’s like

Inside Accelerate